FNY Investment Advisers »

Mineralys Therapeutics shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-06-30 $20k 1.5k 13.33
2025-03-31 $24k 1.5k 15.33

More positions owned by FNY Investment Advisers

Verona Pharma Plc ads (VRNA)
NVIDIA Corporation (NVDA)
UnitedHealth (UNH)
Sibanye Stillwater Adr Rep 4 Ord Sponsored Adr (SBSW)
Copper Property Control Pass-T (CPPTL)
Codere Online Luxembourg Ord (CDRO)
iShares Barclays 20+ Yr Treas.Bond (TLT)
Microsoft Corporation (MSFT)
Fnma 0.000 preferred (FNMFN)
Churchill Cap Corp X
Seagate Technology Com Stk
Futurecrest Acquisition Corp
Sigma Lithium Corporation (SGML)
Taiwan Semiconductor Mnftg Adr 5 Ord Sponsored Adr (TSM)
Boeing Company (BA)

View all positions for FNY Investment Advisers

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
BlackRock
Vanguard Group
Caligan Partners
Capital Research and Management Company - Division 3
Citadel Advisors
Suvretta Capital Management
Sr One Capital Management
FMR
Franklin Resources
Point72 Asset Management
Laurion Capital Management
Farallon Capital Management

View all funds holding Mineralys Therapeutics